Alnylam Pharmaceuticals, Inc. (NASDAQ:ALNY)

Top Analyst Upgrades and Downgrades: Amarin, Baker Hughes, Canopy Growth, Home Depot, Intelsat, J&J, Replimune, Schlumberger, Transocean and More

Markets have hit new highs recently, but the main indexes were all marginally lower on Wednesday morning. With the Dow Jones industrials up over 28,000 and the S&P 500 over ...
Read Full Story »

Should Alnylam Pharma Be Getting More Credit for Its Regeneron Deal?

Alnylam Pharmaceuticals Inc. (NASDAQ: ALNY) and Regeneron Pharmaceuticals Inc. (NASDAQ: REGN) have announced a collaboration to discover, develop and commercialize new RNA interference (RNAi) therapeutics for a broad range of ...
Read Full Story »

Top Analyst Upgrades and Downgrades: Akamai, Dollar Tree, Hasbro, Intel, Mylan, Netflix, Papa John’s and More

The futures seesawed somewhat Monday morning as investors continued to keep a wary eye on some global hot spots, not the least of which is the ongoing situation in Turkey. ...
Read Full Story »

Top Analyst Upgrades and Downgrades: Broadcom, CBS, Etsy, Illumina, PulteGroup, SeaWorld, Wynn Resorts, Zillow and More

Stocks were indicated to higher on Tuesday after Monday's recovery rally. Investors have seen a very strong earnings season, with 80% of the S&P 500 reporting earnings and over 70% ...
Read Full Story »

Major Biopharma Catalysts, Conferences and Decisions to Watch For in April

Companies in the biotech and pharmaceutical industries are subject to a sizable amount of risk with regards to their drug candidates passing clinical trials and gaining regulatory approval. But with ...
Read Full Story »

Top Analyst Upgrades and Downgrades: Accenture, Amex, Cognizant, FireEye, Mastercard, PayPal, Verizon, Visa and More

Stocks tried to continue Monday's gains on Tuesday, but the market failed to hold its rally with a big late-day sell-off. The major indices were set to open higher on ...
Read Full Story »

Even More Biopharma Catalysts Coming Through the End of March

Biotech and pharmaceutical companies are generally involved in the lengthy process of getting their drug candidates to market through clinical trials. The amount of risk involved ranges from fair to ...
Read Full Story »

Top 10 Biopharma Events Kicking Off 2018

Biotechnology and pharmaceutical companies generally face a fair-to-great amount of risk based on the lengthy vetting process for their drug candidates, should a study come back negative or should a ...
Read Full Story »

50 Mid-Cap and Larger Stocks More Than Doubled in 2017

With 2017 nearing an end, it is important to consider just what has happened. Tax reform looks very likely now, and gross domestic product is higher in the United States ...
Read Full Story »

Top Analyst Upgrades and Downgrades: AMD, Chevron, GM, Intel, Merck, Nokia, Under Armour and More

Stocks were indicated to open lower on Monday after hitting all-time highs last week. With the bull market now nearing nine years old, the one trend that has prevailed for ...
Read Full Story »

Top Analyst Upgrades and Downgrades: AbbVie, Baker Hughes, CSX, Micron, Nucor, PepsiCo, Western Digital and More

Stocks were indicated to open higher on Monday after hitting all-time highs the prior week. The one trend that has been proven time after time in this eight-year bull market ...
Read Full Story »

Top Analyst Upgrades and Downgrades: Axovant, Carnival, Micron, Nike, SunPower, Vivint Solar, Walgreens and More

Stocks have sold off in recent days, with a four-day losing streak for the Dow Jones Industrial Averages. Wednesday was showing some strength after the president's tax plan is being shown ...
Read Full Story »

Top Analyst Upgrades and Downgrades: AMD, Biogen, Capital One, Intuit, Jinko Solar, Micron, Albermarle, Alnylam and More

Stocks were indicated to open marginally lower on Thursday. This is on the heels of Wednesday's confirmation by Janet Yellen that the Federal Reserve would start selling down its $4.5 ...
Read Full Story »

Why Alnylam Pharmaceuticals Is Wednesday’s Top Stock

Alnylam Pharmaceuticals Inc. (NASDAQ: ALNY) saw its shares make a handy gain on Wednesday after the firm gave an update on its late-stage trial in patients with hereditary ATTR amyloidosis ...
Read Full Story »

Top Analyst Upgrades and Downgrades: Alibaba, BHP Billiton, Cintas, Monsanto, Schlumberger, Shopify, Hess, Western Digital and More

Stocks were indicated to open marginally lower on Tuesday, with no real pull from major news one way or the other. The bull market is now well over eight years ...
Read Full Story »